-0.04 (-0.716%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Neutral
Earnings
Neutral
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Very Weak
Website
ENDRA Life Sciences Inc.
Telephone
1.734.335.0468
Address
Suite 350, 3600 Green Court, Ann Arbor, MI 48105-1570
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.91 - 11.96
Trade Value (12mth)
US$987,707.00
1 week
10.69%
1 month
8.12%
YTD
30.3%
1 year
80.91%
All time high
205800.00
EPS 3 yr Growth
-99.90%
EBITDA Margin
0.00%
Operating Cashflow
-$5m
Free Cash Flow Return
-182.80%
ROIC
-247.80%
Interest Coverage
0.00
Quick Ratio
1.30
Shares Outstanding (Fully Diluted)
1m
HALO Sector
Healthcare
Next Company Report Date
01-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 16 May 26 | |
| 16 May 26 | |
| 21 April 26 | |
| 21 April 26 | |
| 21 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -2,766.52 | -56.94 | -8.93 | | | | ||
EPS (Fully Diluted) | $ | | | | | -2,766.52 | -56.94 | -8.93 | | | | ||
Growth | % | | | | | 65.3 | 97.9 | 84.3 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
